Market Outlook:
Dental Bone Grafts Substitutes Market crossed USD 820.18 Million in 2023 and is set to reach USD 1.87 Billion by end of the year 2032, witnessing more than 9.6% CAGR between 2024 and 2032.
Base Year Value (2023)
USD 820.18 Million
19-23
x.x %
24-32
x.x %
CAGR (2024-2032)
9.6%
19-23
x.x %
24-32
x.x %
Forecast Year Value (2032)
USD 1.87 Billion
19-23
x.x %
24-32
x.x %
Historical Data Period
2019-2023
Largest Region
North America
Forecast Period
2024-2032
Get more details on this report -
Market Dynamics:
Growth Drivers & Opportunity: The increasing prevalence of dental disorders and the rising number of dental implant procedures are driving the growth of the dental bone graft substitutes market. Additionally, the growing elderly population globally, who are more susceptible to dental problems, is creating a significant demand for dental bone graft substitutes. Furthermore, the advancements in technology and materials used in dental bone graft substitutes are also fueling market growth.
Industry
Report Scope
Report Coverage | Details |
---|
Segments Covered | Material Type, Application, End-user |
Regions Covered | • North America (United States, Canada, Mexico)
• Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC)
• Latin America (Argentina, Brazil, Rest of South America)
• Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Medtronic, Stryker, Johnson & Johnson, Zimmer Biomet Holdings,, Baxter International, NuVasive,, Integra LifeSciences, Wright Medical Group N.V., Olympus, RTI Surgical Holdings, |
Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!
The high cost associated with dental bone graft procedures is a major restraint for market growth. This can limit the adoption of dental bone graft substitutes, especially among cost-conscious patients. Another restraint is the potential risk of complications and failure associated with dental bone graft procedures, which can deter patients from opting for these treatments.